Voloridge Investment Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-353,961
| Closed | -$8.97M | – | 1162 |
|
|
2024
Q2 | $8.97M | Sell |
353,961
-1,042,458
| -75% | -$26.4M | 0.03% | 590 |
|
|
2024
Q1 | $43.2M | Buy |
1,396,419
+290,430
| +26% | +$8.98M | 0.16% | 187 |
|
|
2023
Q4 | $44.6M | Sell |
1,105,989
-143,669
| -11% | -$5.8M | 0.18% | 159 |
|
|
2023
Q3 | $33M | Buy |
1,249,658
+770,207
| +161% | +$20.3M | 0.16% | 172 |
|
|
2023
Q2 | $8.25M | Sell |
479,451
-563,035
| -54% | -$9.68M | 0.04% | 518 |
|
|
2023
Q1 | $17.3M | Buy |
1,042,486
+411,775
| +65% | +$6.83M | 0.09% | 325 |
|
|
2022
Q4 | $4.81M | Sell |
630,711
-190,350
| -23% | -$1.45M | 0.03% | 651 |
|
|
2022
Q3 | $8.16M | Buy |
821,061
+730,510
| +807% | +$7.26M | 0.04% | 507 |
|
|
2022
Q2 | $822K | Sell |
90,551
-351,412
| -80% | -$3.19M | ﹤0.01% | 1234 |
|
|
2022
Q1 | $4.49M | Buy |
441,963
+206,545
| +88% | +$2.1M | 0.03% | 674 |
|
|
2021
Q4 | $3.93M | Buy |
+235,418
| New | +$3.93M | 0.02% | 802 |
|
|
2021
Q1 | – | Sell |
-119,021
| Closed | -$8.46M | – | 1391 |
|
|
2020
Q4 | $8.46M | Sell |
119,021
-34,854
| -23% | -$2.48M | 0.07% | 318 |
|
|
2020
Q3 | $5.77M | Buy |
153,875
+95,934
| +166% | +$3.6M | 0.05% | 411 |
|
|
2020
Q2 | $1.89M | Buy |
+57,941
| New | +$1.89M | 0.02% | 642 |
|